By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it started two new collaborations to deploy its digital tomosynthesis system Nanox.ARC across the U.S. The first partnership aims to use 12 Nanox.ARC with Integrity Medical Service in Colorado, Wyoming and...

By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said it will request an Investigational Device Exemption (IDE) from the FDA for its continuous blood glucose monitoring technology. This submission follows the completion of clinical trials in Brazil and Australia, and is...

By Karen Roman SkylineDx said its Merlin CP-GEP molecular test identifies a subset of T1a melanoma patients with sentinel lymph node (SLN) positivity above guideline thresholds. The National Comprehensive Cancer Network updated its guidelines recognizing the Merlin CP-GEP as the...

By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) said it presented new research findings at the International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders taking place March 17-21, 2026, in Copenhagen and online. The data displays efforts...

By Daniella Parra Acumen Pharmaceuticals said it will present new research on its Alzheimer’s treatment candidate at the International Conference on Alzheimer’s and Parkinson’s Diseases 2026 in Copenhagen. The company will include one oral session and two posters highlighting advances...

By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it is collaborating with three new partners to expand its imaging solutions across the globe. The company is partnering with Australian-based Harrison.ai to add Nanox’s AI solutions to its AI platform and...

By Karen Roman Sequana Medical said the company now has five medical centers using its alfapump, the first FDA-approved active implantable medical device to treat liver ascites due to cirrhosis. The new implantations include the Dartmouth Hitchcock Medical Center and...

By Karen Roman SkylineDx said its Merlin CP-GEP molecular test is uniquely recognized by the National Comprehensive Cancer Network (NCCN) for predictive use in select T1 and T2 melanoma patients. The test provides informed risk stratification and helps physicians better understand...

By Karen Roman Now Optics, the parent company of Stanton Optical, said it is opening the first four “store-in-store” locations inside select Staples stores in the Philadelphia area. The stores will open in Wayne, Springfield, Bensalem and Willow Grove and...

By Exec Edge Editorial Staff Ascentage Pharma said China’s Center for Drug Evaluation has cleared its investigational new drug application for APG-3288, a next-generation Bruton’s tyrosine kinase (BTK) protein degrader, paving the way for clinical testing in the country and...